In addition, our data highlight that in this tumor layer, there is a slight but not statistically significant reduction of IL‐17 production, which is proposed to have an antitumor activity [40], suggesting an immune suppression of TILs, in particular of Th17 and Th1/17 like cells in the intermediate layer. Here, IL17A is linked to neoplasm.